throbber
Optometric Management - How to Maximize Prescription Authority
`
`https://www.optometricmanagement.com/issues/2006/november-2006/...
`
`Article
`
`How to Maximize Prescription Authority
`Put your training into action with these proven steps.
`
`November 1, 2006
`
`1
`
`prescription authority
`
`MAXIMIZE Prescription Authority
`Here's how to put your training into action.
`MICHELLE BOYLES, Managing Editor
`
`According to statistics from the 2004 AOA Scope of Practice Survey (the last year for which numbers are available),
`O.D.s diagnosed about 36% more patients with glaucoma in 2004 versus 2002, and 23% more with other anterior
`segment disorders. However, optometrists with appropriate prescribing authority in 2004 treated or co-managed 66% of
`the glaucoma patients they diagnosed and 85% of those diagnosed with anterior segment disorders. A recent survey by
`the National Board of Examiners in Optometry found that ocular disease treatment is an integral part of optometric
`practice and that prescribing topical medications, both legend and over-the-counter, is a primary treatment option. But
`only 13% of optometric examinations were disease-related.
`
`As optometry moves to encompass the medical model and Baby Boomers age, you will find greater opportunities to
`manage patients who suffer from eye disease. Providing prescriptions will enhance patient care, boost your confidence
`and benefit your practice.
`
`Therapeutics Most Prescribed By O.D.s by Category
`
`Average number of prescriptions written in a six-month period.
`
`Dry Eye
`
`Antimicrobials
`
`Allergy
`
`Glaucoma
`
`Anti-inflammatory/steroids
`
`Vitamin
`
`108
`
`69
`
`68
`
`46
`
`45
`
`44
`
`1 of 7
`
`8/22/2022, 3:42 PM
`
`Eye Therapies Exhibit 2116, 1 of 7
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Optometric Management - How to Maximize Prescription Authority
`
`https://www.optometricmanagement.com/issues/2006/november-2006/...
`
`*Numbers from 2004 AOA Scope of Practice Survey.
`
`Practice evolution
`
`There are numerous reasons why it's important for optometry to increase prescriptions. On a professional level, it helps
`support expanded scope-of-practice. There are also some who posit that utilizing prescription authority is essential to
`optometry's evolution. "Any profession, or professional, who does not continue to expand and meet the challenges of
`new technologies will be driven to extinction," says Tom Annunziato, O.D., president of the Texas optometric
`Association. "Today's practices won't grow if they don't adopt the medical model," says optometrist Douglas DeVries of
`Sparks, Nev.
`
`Writing prescriptions may also improve your standing with pharmaceutical representatives. Most of these companies
`track the number of prescriptions written for a given product, where the prescriptions are filled and who wrote the script.
`Some studies have shown a discrepancy in the number of prescriptions O.D.s report writing and the actual number of
`prescriptions attributed to them. But new regu- lations under HIPAA may change that. (See "Rx Tracking" on page 43.)
`
`Over the counter products
`
`It's important for patients to receive timely and accurate care. And writing a script for those conditions you know how to
`treat is important to your practice because it elevates you in the patient's eyes. Studies have shown that patients take a
`written prescription more seriously than a general recommendation. "The act of writing a prescription, whether for over-
`the-counter or prescription medications, is very powerful," says Carla Mack, O.D., Director of Clinics at the Ohio State
`University College of Optometry and author of OM's Coding column. "It's something physical ... that reinforces to the
`patient that you have the expertise and experience to care for that patient's needs," she says. So, don't just write
`prescriptions for medications that require them, write down the appropriate contact lens solution, dry eye treatment or
`nutritional supplement and hand it over to the patient.
`
`Where Optometry is Restricted
`
`Dots show in which states O.D.s can't prescribe certain medications.
`
`STATE
`
`Alaska
`
`Arizona
`
`California
`
`Colorado
`
`Delaware
`
`GLAUCOMA
`
`ORAL STEROIDS
`
`ORAL PAIN
`
`NARCOTICS
`
`•
`
`•
`
`•
`
`•
`
`•
`
`2 of 7
`
`8/22/2022, 3:42 PM
`
`Eye Therapies Exhibit 2116, 2 of 7
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Optometric Management - How to Maximize Prescription Authority
`
`https://www.optometricmanagement.com/issues/2006/november-2006/...
`
`District of Columbia
`
`Florida
`
`Hawaii
`
`Illinois
`
`Indiana
`
`Maine
`
`Maryland
`
`Massachusetts
`
`•
`
`Michigan
`
`Minnesota
`
`Mississippi
`
`Nebraska
`
`new Hampshire
`
`New Mexico
`
`New York
`
`Ohio
`
`Rhode Island
`
`Texas
`
`Washington
`
`Wyoming
`
`•
`
`•
`
`•
`
`•
`
`•
`
`•
`
`•
`
`•
`
`•
`
`•
`
`•
`
`•
`
`•
`
`•
`
`•
`
`•
`
`•
`
`•
`
`•
`
`•
`
`•
`
`* Information derived from the American Optometric Association's State Government Relations Center.
`
`"Without specific direction, a patient is bombarded with too many options when it comes to all over-the-counter
`medications," says Dr. Annunziato. "Without a professional's guidance, the patient is susceptible to the best-marketed
`products on the shelves."
`
`3 of 7
`
`8/22/2022, 3:42 PM
`
`Eye Therapies Exhibit 2116, 3 of 7
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Optometric Management - How to Maximize Prescription Authority
`
`https://www.optometricmanagement.com/issues/2006/november-2006/...
`
`Most patients aren't familiar with the differences in OTC products. "I believe when you recommend an over-the- counter
`product, you should always prescribe," says Dr. DeVries, "If you just say, 'artificial tear' patients will buy whatever is
`cheapest and end up doing more damage than good."
`
`Patients are also often forgetful. A written prescription will both remind them of the right product and reinforce the
`importance of the proper treatment.
`
`Serving the Baby Boomers
`
`The future will also bring more patients into your office with conditions that require medical management like surgery
`and age-related eye disease. Currently, most cataract patients are over the age of 60. In the next 15 years, 80 million
`Americans will reach the age of retirement. Age-related eye diseases are becoming more prevalent partly as the result
`of Americans' longer life span. "Think of the impact it would make if the doctor records on a prescription pad that he
`would like the patient to return in six months for re-evaluation of cataracts as compared to the office reception staff
`advising the patient call back in six months to schedule and appointment," Dr. Mack says.
`
`Numerous ongoing studies will investigate other treatments for primary care patients. As these patients are likely to take
`systemic medications or supplements as well, it becomes imperative that optometrists understand the interaction
`between therapies and communicate them, so that patients avoid any dangerous interaction between drugs.
`
`Treating glaucoma
`
`The National Board of Examiners in Optometry's 2006 Practice of Optometry survey lists glaucoma medications at the
`top of those prescribed by O.D.s. In these cases, it often takes many attempts to find the right medication or
`combination to sufficiently lower a patient's IOP. Because glaucoma drops are expensive, many O.D.s give patients a
`sample to test efficacy and only write the script after they know the medication works for that patient. Dr. DeVries
`cautions against this, however. "Avoid going to the sample before writing the script," he says, "Then reappoint for follow-
`up to make sure the medication has adequately addressed the problem. The patient might need additional therapies."
`
`Dr. Mack says, "We have the ability and legal authority to prescribe and care for many of these patient's acute and
`chronic needs. I believe we should prescribe for those conditions we feel comfortable with and have the legal authority
`to do so."
`
`Contact lens care
`
`"No one in this country is more qualified than an optometrist to counsel and direct a patient to the proper use of OTC
`contact lens solutions and rewetting drops," says Dr. Annunziato, "The Fusarium outbreak has taught us that lesson."
`
`Newer silicone hydrogel lenses are not compatible with every care system and rewetting drop. Using the wrong product
`could damage not only a patient's eyes, but also the lenses themselves.
`
`Prescribing Dietary Supplements
`
`4 of 7
`
`8/22/2022, 3:42 PM
`
`Eye Therapies Exhibit 2116, 4 of 7
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Optometric Management - How to Maximize Prescription Authority
`
`https://www.optometricmanagement.com/issues/2006/november-2006/...
`
`Many patients today have shown a renewed interest in the role of dietary supplements. The Dietary Supplement Health and Education
`
`Act (DSHEA) of 1994 defines a dietary supplement as a product taken by mouth that contains a dietary ingredient that may include
`
`vitamins, minerals, herbs or other botanicals, amino acids and substances such as enzyme, organ tissues, glandulars and metabolites.
`
`The DSHEA created a new regulatory framework for the safety and labeling of dietary supplements and place them in the general
`
`category of foods, not drugs, so they do not require the approval of the U.S. Food and Drug Administration (FDA). Under this law,
`
`manufacturers are responsible for determining that its supplements are safe and to substantiate any claims made about the product.
`Most Americans, however, don't know this. They see a bottle on the shelves of the local drug store that sometimes looks identical to
`over-the-counter medications and mistakenly believe the two products have undergone the same scrutiny. Prescribing the appropriate
`supplement will help patients avoid confusion in the aisles and keep them safe from dangerous side effects.
`
`The Federal Trade Commission lists some common misconceptions among consumers:
`
`BELIEF: The term "natural" means safe.
`
`Truth: Although many supplements can be used safely by most people, others, including some herbal products, can be dangerous. Even
`
`certain vitamins can be toxic at high doses.
`
`BELIEF: Dietary supplements are safer than prescription drugs because they do not require a professional's supervision.
`
`Truth: Studies have shown that some herbal products interact with drugs and can have a wide range of effects. For example, St. John's
`
`Wort can lower the effects of certain HIV drugs and may interfere drugs used to treat depression.
`
`Get involved
`
`O.D.s who graduated from optometry school years ago may not feel comfortable prescribing newer medications. Dr.
`DeVries suggests starting with lower-morbidity disease entities such as allergy and chronic dry eye. "This is a great way
`to start to build a therapeutic subspecialty," he says. "Have an understanding of what acute or chronic disease
`processes you will feel most comfortable and have an interest in treating," Dr. Mack adds.
`
`Dr. DeVries and Dr. Mack agree that continuing education seminars can help. "Continuing education will help bring you
`up-to-speed," says Dr. DeVries. "Go to major meetings such as the American Academy of Optometry and the American
`Optometric Association annual meetings and learn and communicate with your peers," says Dr. Mack, "Understand the
`current pharmaceuticals, their costs and side effects."
`
`Dr. DeVries also suggests attending a specialty-oriented meeting. "Instead of an hour here or two hours there, you
`spend all day learning how to treat specific entity." Dr. Mack concurs, "Not a day goes by that we aren't receiving
`e-mails about these day or weekend courses that incorporate practice management as well," she says.
`
`Educating staff and patients
`
`You'll need to re-educate your staff and patients also. "Your staff has to buy into it," says Dr. DeVries.
`
`"Relying on qualified ophthalmic technicians is crucial to a medical practice," says Dr. Annunziato. "Optometrists ... must
`learn to be data interpreters, rather than data gatherers."
`
`He explains that 30 years ago, O.D.s could see 12 to 15 patients a day and make a reasonable living. Today, he says
`you need to see anywhere from 25 to 50 patients a day to maintain a standard practice. "A single practitioner gathering
`all his own data will not be able to meet this crushing demand," he says.
`
`5 of 7
`
`8/22/2022, 3:42 PM
`
`Eye Therapies Exhibit 2116, 5 of 7
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Optometric Management - How to Maximize Prescription Authority
`
`https://www.optometricmanagement.com/issues/2006/november-2006/...
`
`"Staff need to know that the doctor is going to be treating a wider range of patients," Dr. DeVries says. He suggests
`having a pharmaceutical representative host a "lunch and learn" with the staff.
`
`Rx Tracking
`
`Prescription tracking is the process through which pharmaceutical companies determine how many patients with a given condition you
`
`see and what medications you tend to prescribe for them. The data is gathered through a pharmacy-reporting program and used to
`
`plan marketing efforts. A 2003 study at the University of Missouri-St. Louis College of Optometry showed a significant difference in
`
`between the numbers of O.D.-written prescriptions reported by pharmaceutical companies and the number self-reported by O.D.s. In
`
`some cases, optometrists were under-credited by more than 90 prescriptions a month.
`
`This could all change with the implementation of National Provider Identifier (NPI) numbers, a ten-digit number that will be used as a
`uniform means of health care provider identification. Under HIPAA, all public and private health insurance plans will have to recognize
`NPIs on electronically filed claims and many other transactions. HIPAA will not require the use of NPIs for prescriptions, but Medicare will
`require them for electronic prescriptions beginning in May 2007. And the DEA is strongly urging that NPIs be adopted as the generally-
`accepted means of prescriber identification for pharmaceutical prescriptions. It's uncertain when prescription-tracking services will begin
`using NPIs, but it may not be far off. You can apply for an NPI online, through the National Plan and Provider Enumeration System at
`https://nppes.cms.hhs.gov/NPPES/Welcome.do.
`
`Annunziato T, Coble T. Appropriate use of pharmaceutical samples in the optometric practice. Optometry. 2006 Aug;77(8):405-12.
`
`"Office staff often have lengthy conversation with your patients," says Dr. Mack, "They must internally promote all the
`services that you provide."
`
`Marketing tools, such as on-hold messages, waiting room placards, etc., can alert patients to your new sub-specialty.
`"The timing of your message is critical," says Dr. Mack. "For example, right before allergy season, send a postcard,
`newsletter or e-newsletter out letting your patients know about the signs and symptoms of allergies and that you can
`treat them with the newest medications."
`
`Best for the practice
`
`Increasing your prescription authority will bring patients back to your office for continuing care and improve your
`reputation. "Your revenue will increase because the number of times a patient chooses to see you over time will
`increase as you monitor and treat their acute and chronic ocular diseases. The overall patient experience improves
`when they seek your care and you can provide that care and resolve the problem," says Dr. Mack.
`
`Dr. DeVries sums it up, "My feeling is that we need to make our practice as healthy as we make our patients."
`Prescribing appropriately is a good start.
`
`6 of 7
`
`8/22/2022, 3:42 PM
`
`Eye Therapies Exhibit 2116, 6 of 7
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Optometric Management - How to Maximize Prescription Authority
`
`https://www.optometricmanagement.com/issues/2006/november-2006/...
`
`Optometric Management, Issue: November 2006
`Table of Contents
`Archives
`
`Copyright © 2022, PentaVision, Inc. All rights reserved. Privacy Policy
`
`7 of 7
`
`8/22/2022, 3:42 PM
`
`Eye Therapies Exhibit 2116, 7 of 7
`Slayback v. Eye Therapies - IPR2022-00142
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket